Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
United States Revenue	2.87B	2.57B	2.35B
United States Revenue Growth	11.61%	9.52%	19.32%
Outside of United States Revenue	214.03M	189.09M	153.28M
Outside of United States Revenue Growth	13.19%	23.37%	30.19%
Revenue (Other)	-713.42M	-	-
Revenue (Total)	2.37B	2.76B	2.50B
Revenue (Total) Growth	-14.15%	10.37%	19.93%

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Screening Medicare Parts B & C Revenue	881.53M	776.16M	701.40M
Screening Medicare Parts B & C Revenue Growth	13.58%	10.66%	28.59%
Screening Commercial Revenue	1.27B	1.12B	992.24M
Screening Commercial Revenue Growth	13.51%	12.71%	33.50%
Screening Other Service Revenue	236.37M	209.38M	171.06M
Screening Other Service Revenue Growth	12.89%	22.40%	25.77%
Total Screening Revenue	2.39B	2.10B	1.86B
Total Screening Revenue Growth	13.47%	12.83%	30.88%
Precision Oncology Medicare Parts B & C Revenue	190.08M	187.95M	188.69M
Precision Oncology Medicare Parts B & C Revenue Growth	1.14%	-0.39%	-4.38%
Precision Oncology Commercial Revenue	193.70M	190.60M	181.32M
Precision Oncology Commercial Revenue Growth	1.63%	5.12%	2.14%
Precision Oncology International Revenue	214.03M	189.09M	153.28M
Precision Oncology International Revenue Growth	13.19%	23.37%	30.19%
Precision Oncology Other Service Revenue	96.93M	87.36M	105.83M
Precision Oncology Other Service Revenue Growth	10.94%	-17.45%	-2.83%
Total Precision Oncology Revenue	694.74M	655.00M	629.11M
Total Precision Oncology Revenue Growth	6.07%	4.12%	4.59%
COVID-19 Testing Revenue	-	-	5.96M
COVID-19 Testing Revenue Growth	-	-	-89.75%
Revenue (Other)	-713.42M	-	-
Revenue (Total)	2.37B	2.76B	2.50B
Revenue (Total) Growth	-14.15%	10.37%	19.93%

EBT by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
United States Income Before Tax	-1.04B	-204.13M
Outside of United States Income Before Tax	145.00K	2.38M
Outside of United States Income Before Tax Growth	-93.91%	-

Updated Feb 13, 2026. Data Source: Fiscal.ai.